Search

Search Constraints

You searched for: Journal AIDS

Search Results

11. A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders. (1st November 2022)

13. A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus. (27th March 2016)

14. A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus. (27th March 2016)

15. A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults. (1st February 2022)

16. A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults. (1st February 2022)

17. A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients. (13th March 2018)